4DMedical (ASX:4DX) secured a commercial contract with Utah-based Intermountain Health to implement its pulmonary hypertension analysis product, according to a Monday filing with the Australian bourse.
The pulmonary hypertension analysis product is an artificial-intelligence-based algorithm designed for acute care settings to aid response teams in assessing pulmonary hypertension due to pulmonary embolism, the filing said.
The contract was secured through Microsoft-owned Nuance Communications as part of the company's strategic distribution partnership, according to the filing.
4DMedical shares were up 5% in morning trade on Monday.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。